These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 14712987)
1. Effect of oestrogen replacement therapy on serum lipid profile. Nanda S; Gupta N; Mehta HC; Sangwan K Aust N Z J Obstet Gynaecol; 2003 Jun; 43(3):213-6. PubMed ID: 14712987 [TBL] [Abstract][Full Text] [Related]
2. Long-term influence of different postmenopausal hormone replacement regimens on serum lipids and lipoprotein(a): a randomised study. Hänggi W; Lippuner K; Riesen W; Jaeger P; Birkhäuser MH Br J Obstet Gynaecol; 1997 Jun; 104(6):708-17. PubMed ID: 9197875 [TBL] [Abstract][Full Text] [Related]
3. The influence of transdermal oestradiol replacement therapy and medroxyprogesterone acetate on serum lipids and lipoproteins. Bhathena RK; Anklesaria BS; Ganatra AM; Pinto R Br J Clin Pharmacol; 1998 Feb; 45(2):170-2. PubMed ID: 9491833 [TBL] [Abstract][Full Text] [Related]
4. Long-term effects of oral and transdermal hormone replacement therapies on serum lipid and lipoprotein concentrations. Whitcroft SI; Crook D; Marsh MS; Ellerington MC; Whitehead MI; Stevenson JC Obstet Gynecol; 1994 Aug; 84(2):222-6. PubMed ID: 8041534 [TBL] [Abstract][Full Text] [Related]
5. A randomised comparison of the effects of oral versus transdermal 17beta-oestradiol, each combined with sequential oral norethisterone acetate, on serum lipoprotein levels. Spencer C; Crook D; Ross D; Cooper A; Whitehead M; Stevenson J Br J Obstet Gynaecol; 1999 Sep; 106(9):948-53. PubMed ID: 10492107 [TBL] [Abstract][Full Text] [Related]
6. Phasic serum lipid excursions occur during cyclical oral conjugated oestrogens but not during transdermal oestradiol sequentially combined with oral medroxyprogesterone acetate. Lemay A; Dodin S; Cédrin I; T-Lemay L Clin Endocrinol (Oxf); 1995 Apr; 42(4):341-51. PubMed ID: 7750187 [TBL] [Abstract][Full Text] [Related]
7. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus. Araújo DA; Farias ML; Andrade AT Climacteric; 2002 Sep; 5(3):286-92. PubMed ID: 12419087 [TBL] [Abstract][Full Text] [Related]
8. Metabolic changes induced by peroral oestrogen and transdermal oestradiol gel therapy. Karjalainen A; Heikkinen J; Savolainen MJ; Bäckström AC; Salinto M; Kesäniemi YA Br J Obstet Gynaecol; 1997 Nov; 104 Suppl 16():38-43. PubMed ID: 9389782 [TBL] [Abstract][Full Text] [Related]
10. Substitution of transdermal estradiol during oral estrogen-progestin therapy in postmenopausal women: effects on hypertriglyceridemia. Sanada M; Tsuda M; Kodama I; Sakashita T; Nakagawa H; Ohama K Menopause; 2004; 11(3):331-6. PubMed ID: 15167313 [TBL] [Abstract][Full Text] [Related]
12. [Cyclical gestagen (MPA) supplement for continuous transdermal or oral estrogen substitution in postmenopause: modification of serum lipids]. Hänggi W; Birkhäuser MH; Malek A; Peheim E; von Hospenthal JU Geburtshilfe Frauenheilkd; 1993 Oct; 53(10):709-14. PubMed ID: 8270155 [TBL] [Abstract][Full Text] [Related]
13. Long-term effects of transdermal and oral estrogens on serum lipids and lipoproteins in postmenopausal women. Adami S; Rossini M; Zamberlan N; Bertoldo F; Dorizzi R; Lo Cascio V Maturitas; 1993 Nov; 17(3):191-6. PubMed ID: 8133793 [TBL] [Abstract][Full Text] [Related]
14. [Effects of tamoxifen and estrogen replacement therapy on lipid metabolism and some other cardiovascular risk factors. A prospective study in hysterectomised women]. Imperato F; Marziani R; Perniola G; Ebano V; Fruscella M; Mossa B Minerva Ginecol; 2003 Feb; 55(1):87-93. PubMed ID: 12598849 [TBL] [Abstract][Full Text] [Related]
15. Effects of transdermal 17 beta-oestradiol combined with oral progestogen on lipids and lipoproteins in hypercholesterolaemic postmenopausal women. Słowińska-Srzednicka J; Zgliczyński S; Chotkowska E; Srzednicki M; Stopińska-Głuszak U; Jeske W; Brzezińska A; Zgliczyński W; Sadowski Z J Intern Med; 1993 Nov; 234(5):447-51. PubMed ID: 7693846 [TBL] [Abstract][Full Text] [Related]
16. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women. Zegura B; Guzic-Salobir B; Sebestjen M; Keber I Menopause; 2006; 13(4):643-50. PubMed ID: 16837886 [TBL] [Abstract][Full Text] [Related]
17. Comparison of effects of continuous combined transdermal with oral estrogen and oral progestogen replacement therapies on serum lipoproteins and compliance. Erenus M; Karakoç B; Gürler A Climacteric; 2001 Sep; 4(3):228-34. PubMed ID: 11588947 [TBL] [Abstract][Full Text] [Related]
18. Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins. Vrablik M; Fait T; Kovar J; Poledne R; Ceska R Metabolism; 2008 Aug; 57(8):1088-92. PubMed ID: 18640386 [TBL] [Abstract][Full Text] [Related]
19. Effects of estrogen replacement on plasma lipoproteins and apolipoproteins in postmenopausal, dyslipidemic women. Granfone A; Campos H; McNamara JR; Schaefer MM; Lamon-Fava S; Ordovas JM; Schaefer EJ Metabolism; 1992 Nov; 41(11):1193-8. PubMed ID: 1435290 [TBL] [Abstract][Full Text] [Related]
20. Effects of oral and transdermal hormone replacement therapy on lipoprotein(A) and lipids: a randomized controlled trial. Meschia M; Bruschi F; Soma M; Amicarelli F; Paoletti R; Crosignani P Menopause; 1998; 5(3):157-62. PubMed ID: 9774761 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]